| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |